Steve Mandel's MDLN Position Overview
Steve Mandel (via Lone Pine Capital LLC) currently holds 20.97 M shares of Medline Inc. (MDLN) worth $826.99 M, representing 5.06% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Steve Mandel has maintained this position in MDLN for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 9.18 M shares.
Analysis based on 13F filings available since 2013 Q2
Steve Mandel's Medline (MDLN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medline (MDLN) Trades by Steve Mandel
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +9.18 M | Add 77.86% | 20.97 M | $39.44 |
| Q1 2026 | +72,459 | Add 0.62% | 11.79 M | $44.50 |
| Q4 2025 | +11.72 M | New Buy | 11.72 M | $42.00 |
Steve Mandel's Medline Investment FAQs
Steve Mandel first purchased Medline Inc. (MDLN) in Q4 2025, acquiring 11,716,697 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steve Mandel has held Medline Inc. (MDLN) for 3 quarters since Q4 2025.
Steve Mandel's largest addition to Medline Inc. (MDLN) was in Q4 2025, adding 11,716,697 shares worth $492.1 M.
According to the latest 13F filing for Q2 2026, Steve Mandel's firm, Lone Pine Capital LLC, owns 20,968,367 shares of Medline Inc. (MDLN), valued at approximately $826.99 M.
As of the Q2 2026 filing, Medline Inc. (MDLN) represents approximately 5.06% of Steve Mandel's publicly disclosed stock portfolio, making it one of their key holdings.
Steve Mandel's peak holding in Medline Inc. (MDLN) was 20,968,367 shares, as reported at the end of Q2 2026.